BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34091531)

  • 21. Epigenetic inactivation of SFRP genes in oral squamous cell carcinoma.
    Sogabe Y; Suzuki H; Toyota M; Ogi K; Imai T; Nojima M; Sasaki Y; Hiratsuka H; Tokino T
    Int J Oncol; 2008 Jun; 32(6):1253-61. PubMed ID: 18497987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of WNT-1 on beta-catenin expression and its relation to Ki-67 and tumor differentiation in oral squamous cell carcinoma.
    Zhang WM; Lo Muzio L; Rubini C; Yan G
    Oncol Rep; 2005 Jun; 13(6):1095-9. PubMed ID: 15870927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA, TUG1 regulates the oral squamous cell carcinoma progression possibly via interacting with Wnt/β-catenin signaling.
    Liang S; Zhang S; Wang P; Yang C; Shang C; Yang J; Wang J
    Gene; 2017 Apr; 608():49-57. PubMed ID: 28119088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. lncRNA PLAC2 activated by H3K27 acetylation promotes cell proliferation and invasion via the activation of Wnt/β‑catenin pathway in oral squamous cell carcinoma.
    Chen F; Qi S; Zhang X; Wu J; Yang X; Wang R
    Int J Oncol; 2019 Apr; 54(4):1183-1194. PubMed ID: 30720068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epithelial to mesenchymal transition (EMT) biomarkers--E-cadherin, beta-catenin, APC and Vimentin--in oral squamous cell carcinogenesis and transformation.
    Chaw SY; Abdul Majeed A; Dalley AJ; Chan A; Stein S; Farah CS
    Oral Oncol; 2012 Oct; 48(10):997-1006. PubMed ID: 22704062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. β-catenin expression in areca quid chewing-associated oral squamous cell carcinomas and upregulated by arecoline in human oral epithelial cells.
    Lee SS; Tsai CH; Tsai LL; Chou MC; Chou MY; Chang YC
    J Formos Med Assoc; 2012 Apr; 111(4):194-200. PubMed ID: 22526207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MFAP2 promotes the progression of oral squamous cell carcinoma by activating the Wnt/β-catenin signaling pathway through autophagy.
    Zhang H; Shen S; Feng C; Chen G; Wang X
    Acta Biochim Biophys Sin (Shanghai); 2023 Aug; 55(9):1445-1455. PubMed ID: 37592847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noncalcemic Vitamin D Hydroxyderivatives Inhibit Human Oral Squamous Cell Carcinoma and Down-regulate Hedgehog and WNT/β-Catenin Pathways.
    Oak ASW; Bocheva G; Kim TK; Brożyna AA; Janjetovic Z; Athar M; Tuckey RC; Slominski AT
    Anticancer Res; 2020 May; 40(5):2467-2474. PubMed ID: 32366390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic restraint stress promotes the tumorigenic potential of oral squamous cell carcinoma cells by reprogramming fatty acid metabolism via CXCL3 mediated Wnt/β-catenin pathway.
    Lou F; Long H; Luo S; Liu Y; Pu J; Wang H; Ji P; Jin X
    Exp Neurol; 2023 Jan; 359():114268. PubMed ID: 36343679
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Tang KL; Tang HY; Du Y; Tian T; Xiong SJ
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3278-3285. PubMed ID: 31379206
    [No Abstract]   [Full Text] [Related]  

  • 31. Aberrant β-catenin expression in the histologic differentiation of oral squamous cell carcinoma and verrucous carcinoma: an immunohistochemical study.
    Laxmidevi LB; Angadi PV; Pillai RK; Chandreshekar C
    J Oral Sci; 2010 Dec; 52(4):633-40. PubMed ID: 21206167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KLK4 silencing inhibits the growth of oral squamous cell carcinoma through Wnt/β-catenin signaling pathway.
    Cui Z; Cui Y; Yang S; Luo G; Wang Y; Lou Y; Sun X
    Cell Biol Int; 2017 Apr; 41(4):392-404. PubMed ID: 28150891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The expression of E-cadherin, vimentin, β-catenin, transforming growth factor-β1 in oral squamous cell carcinomas].
    Zhang L; Lu Z; Yin C; Xia M; Xie S
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Apr; 50(4):228-34. PubMed ID: 26081960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study of β-catenin, E-cadherin and vimentin in oral squamous cell carcinoma with and without lymph node metastases.
    Balasundaram P; Singh MK; Dinda AK; Thakar A; Yadav R
    Diagn Pathol; 2014 Jul; 9():145. PubMed ID: 25047112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased expression of lncRNA FTH1P3 promotes oral squamous cell carcinoma cells migration and invasion by enhancing PI3K/Akt/GSK3b/ Wnt/β-catenin signaling.
    Liu M; Gao X; Liu CL
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8306-8314. PubMed ID: 30556871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysfunction of Cl
    Kei Kakinouchi ; Yoshie S; Tsuji S; Murono S; Hazama A
    Biochem Biophys Res Commun; 2021 May; 555():95-101. PubMed ID: 33813282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway.
    Yang J; Wei D; Wang W; Shen B; Xu S; Cao Y
    Int J Clin Exp Pathol; 2015; 8(9):11837-46. PubMed ID: 26617938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Antihelminthic Niclosamide Inhibits Cancer Stemness, Extracellular Matrix Remodeling, and Metastasis through Dysregulation of the Nuclear β-catenin/c-Myc axis in OSCC.
    Wang LH; Xu M; Fu LQ; Chen XY; Yang F
    Sci Rep; 2018 Aug; 8(1):12776. PubMed ID: 30143678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-191 regulates oral squamous cell carcinoma cells growth by targeting PLCD1 via the Wnt/β-catenin signaling pathway.
    Wang Z; Guan W; Ma Y; Zhou X; Song G; Wei J; Wang C
    BMC Cancer; 2023 Jul; 23(1):668. PubMed ID: 37460940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of lncRNA IGF2BP2-AS1 inhibits proliferation and migration of oral squamous cell carcinoma cells via the Wnt/β-catenin pathway.
    Tong S; Wang X; Guo X; Lu Z
    J Oral Pathol Med; 2022 Mar; 51(3):272-280. PubMed ID: 34637162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.